VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
ZOZO, Inc. vs Amgen Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
ZOZO, Inc.
3092 · Tokyo Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Amgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Amgen Inc. leads (70 / 100 vs 63 / 100 for ZOZO, Inc.).
- Segment focus: ZOZO, Inc. has 5 segments (71.3% in ZOZOTOWN Business); Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: ZOZO, Inc. has 5 moat types across 3 domains; Amgen Inc. has 5 across 3.
Primary market context
ZOZO, Inc.
ZOZOTOWN Business
Japan online fashion marketplace and resale (ZOZOTOWN)
Japan
Consumers (buyers) and fashion brands/retailers (sellers/tenants)
Marketplace operator + retailer (mix of consignment, inventory retail, and used sales)
71.3%
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
ZOZO, Inc. strengths
Amgen Inc. strengths
Segment mix
ZOZO, Inc. segments
Full profile >ZOZOTOWN Business
Oligopoly
LY Corporation Commerce
Competitive
BtoB business
Competitive
Advertising business (ZOZOAD / WEAR reach monetization)
Monopoly
Others (platform services, shipping/settlement fees, and options)
Monopoly
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.